ZEISS Vision Care @ ARVO 2024

Posters dedicated to myopia management

In this area you can find all ZEISS Vision Care posters that were presented at ARVO 2024. We provide a digest with a summary of all study results here. If you are looking for information from ZEISS Medical Technology, please follow this link.

Cristina Alvarez-Peregrina et al.

Efficacy of a next-generation design of ophthalmic lenses for myopia control: 6-month results of the CEME Study

Interim analysis with the next-generation myopia control spectacle lens with C.A.R.E. technology from the CEME study demonstrated to be efficient over six months. Children will continue to be monitored after one and two years of lens wear for a more comprehensive evaluation of the long-term efficacy of the C.A.R.E. spectacle lens in slowing the progression of myopia.

Xiaoqin Chen et al.

Slowing myopia progression with cylindrical annular refractive elements (C.A.R.E.) – 12-month interim results from a 2-year prospective multi-center trial

In children with myopia, after twelve months of lens wear, both ZEISS MyoCare and ZEISS MyoCare S were found to significantly slow myopia progression compared to single vision lenses.

Padmaja Sankaridurg et al.

Probability of surviving fast progression and eye growth reversal after 1-year of spectacle wear with cylindrical annular refractive elements

Probability of surviving fast progression was greater with ZEISS MyoCare than single vision. Whilst 51% of single vision eyes experienced fast progression ( -0.75D or worse) in myopia after twelve months, only 17% of ZEISS MyoCare and 14% of ZEISS MyoCare S wearing eyes experienced fast progression.

Arne Ohlendorf et al.

Myopia control efficacy through Emmetropic Progression Ratio: 1-year of spectacle wear with cylindrical annular refractive elements (C.A.R.E.)

Emmetropic Progression Ratio (EPR) demonstrates that ZEISS MyoCare and ZEISS MyoCare S reduced myopic axial length growth by an average of 70% and 68% compared to emmetropic eye growth. Seven of ten eyes wearing ZEISS MyoCare or ZEISS MyoCare S had eye growth similar to or equivalent to emmetropic eyes.

Christina Boeck-Maier et al.

Impact of parental myopia on myopia control efficacy of spectacle lenses with cylindrical annular refractive elements (C.A.R.E.)

In children wearing single vision spectacle lenses, myopia progressed faster in those with parental myopia. In comparison, in children wearing spectacle lenses incorporating C.A.R.E., myopia progression was not significantly related to parental myopia.

Katharina Rifai et al.

Subjective acceptance of spectacle lenses with cylindrical annular refractive elements (C.A.R.E.) in Chinese children with myopia

High daily wear time was reported with myopic children wearing speacacle lenses incorporating cylindrical annular refractive elements (C.A.R.E.) and no wear time difference compared to single vision lenses. Subjective evaluation of vision for different distances and activities revealed high subjective acceptance, comparable to single vision lenses.

ZEISS MyoCare and ZEISS MyoCare S are not available on the US market.